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methods, in which lipid extraction and derivatization were 
performed simultaneously. For the one-step methods, dif-
ferent methylation periods and the inclusion of a saponifi-
cation reaction were evaluated. Differences in absolute FA 
concentrations were observed among the tested methods, 
in particular for some metabolically relevant FAs such as 
trans elaidic acid and eicosapentaenoic acid. The one-step 
method with saponification and 60 min of methylation time 
was selected since it allowed the identification of a higher 
number of FAs, and was further submitted to in-house vali-
dation. The proposed methodology provides a simple, fast 
and accurate tool to quantitatively analyse FAs in human 
RBCs, useful for clinical and nutritional studies.
Keywords GC-FID · Fatty acids · Red blood cells · One-
step method
Introduction
Fatty acids (FAs) are key molecules in living organisms, 
being involved in several metabolic functions, such as 
energy storage, membrane structure, signal transduction 
cascades and protein acylation [1]. In the past three dec-
ades, several studies have shown a correlation between 
the modern western diet, which is considered to be unbal-
anced due to its richness in n-6 polyunsaturated fatty acids 
(PUFA) and low levels of n-3 PUFA, and the epidemiol-
ogy of some chronic diseases, namely cardiovascular dis-
eases [2–5], diabetes [6–8] cell carcinoma [9], Alzheimer’s 
disease [10] and depression [11], among others. Although 
some epidemiological studies performed so far to evaluate 
the relation between diet and diseases have relied on data 
from food frequency questionnaires to assess dietary intake, 
this approach has several limitations [12]. Therefore, there 
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has been an increased interest in using tissue and blood 
FA composition as biological markers for fat intake [12]. 
Among the blood constituents, plasma is the most fre-
quently used sample in human studies, possibly due to the 
general idea that FA composition of specific tissues follows 
the same pattern than plasma [13], while red blood cells 
(RBCs) are frequently discarded [14]. However, plasma 
lipids are known to be related with recent dietary intake 
and the endogenous processing of lipids, thus being sensi-
tive to dietary fluctuations and representing only a short-
term FA status of the individual [13]. By the contrary, due 
to the long life span of RBCs, approximately 120 days [15], 
their FA profile can be used as a biomarker that reflects a 
longer term dietary macronutrient intake. Additionally, sev-
eral authors have suggested that FA composition of RBCs 
can also be used as an appropriate biomarker to investigate 
patterns of FA metabolism and diseases [3–11].
The analysis of FAs in RBCs typically involves a two-
step procedure with the first step consisting in the extrac-
tion of the total lipids, followed by a second step that 
consists in their methylation, with or without previous 
saponification [16]. Generally, the methodologies used to 
extract total lipids from RBCs are based either in classic 
lipid extraction procedures, namely the Folch method [13, 
14, 17–21] and the modified Bligh and Dyer method [22–
24], or in specific modifications of those methods that gen-
erally involve the change of solvent ratios and/or volumes 
or the use of less toxic solvents. However, this type of pro-
cedure is generally considered to be cumbersome and time 
consuming and can be responsible for sample loss [25, 26]. 
Nevertheless, in several nutritional or biomedical studies 
that included the analysis of RBCs FA profile, classic two-
step extraction methodologies are still being used [3–7, 17, 
18, 21, 34]. The main advantages of one-step compared to 
the two-step procedures are mainly its fastness, precision 
and simplicity [31]. Therefore, in the last years, several 
works are available in the literature focusing on the devel-
opment of one-step procedures (extraction and methylation 
performed on the same vial) concerning the analysis of FAs 
in different biological matrices, in particular human plasma 
[25, 27–31], whole blood [32] and more recently animal or 
human RBCs [16, 25, 33].
As referred, the analysis of FAME composition in RBCs 
is increasingly being reported as a parameter included in 
nutritional assessment or clinical studies. However, to the 
best of our knowledge, most works do not report absolute 
quantification of FAMEs, only giving results as relative 
percentages, and several of them do not even refer the use 
of internal standard [3–5, 18, 21]. Moreover, and possibly 
because GC-FID analysis is such a well-established tech-
nique for the analysis of FAMEs in different matrices, sev-
eral clinical and nutritional studies also do not refer the use 
of calibration with FAME standards (standards only being 
used for peak identification) and most do not give infor-
mation about validation data or refer the use of a validated 
method for RBCs analysis.
For the presented reasons, the proposal of a simple and 
fast one-step methodology specifically validated for the 
quantitative determination of FA composition in RBCs is 
still needed. Therefore, the aims of this study were (1) the 
optimization of a fast one-step methodology for the quanti-
fication of a broad range of FAs in human RBCs using GC-
FID, since it is a more common and affordable equipment 
compared to GC with mass spectrometry detection, being 
suitable for surveys including a large number of samples; 
and (2) the validation of the proposed method. For that pur-
pose, different sample preparation protocols were tested 
and compared, including a classic two-step method (Folch 
method) with slight modifications and different one-step 
methods, in which the inclusion of a saponification reaction 
and the use of different methylation time were evaluated. 
The methodology considered as giving the best results was 
then submitted to in-house validation.
Materials and Methods
Reagents and Standards
Butylated hydroxytoluene (BHT), magnesium sulphate, 
potassium hydroxide and dichloromethane (DCM) were 
purchased from Sigma-Aldrich Chemical Co. (St. Louis, 
USA), physiological salt solution (PSS) containing 0.9 % 
NaCl was purchased from B. Braun Medical (Melsungen, 
Germany), sodium chloride and analytical-grade methanol 
were purchased from AnalaR Normapur (Radnor, USA), 
boron trifluoride methanolic solution (20 % BF3-MeOH) 
was purchased from Merck Schuchardt (Hohenbrunn, Ger-
many) and HPLC grade n-heptane was obtained from Chro-
manorm Co. (Radnor, USA). A mixture of different FAME 
standards (37 Component FAME Mix, reference CRM-
47885) was purchased from Supelco (St. Louis, USA) and 
the internal standard (IS) methyl nonadecanoate (C19:0 
FAME) was purchased from Sigma (St. Louis, USA).
RBCs Sample Preparation
Venous blood samples were collected into 10 mL BD-
Vacutainers® (Franklin Lakes, USA) tubes containing eth-
ylenediaminetetraacetic acid (EDTA). Immediately after 
collection, the whole blood samples were centrifuged at 
2500 rpm for 10 min at 4 °C. After removing the buffy coat 
and plasma of each sample, the packed RBCs were resus-
pended and washed twice in PSS. Finally, BHT was added 
as antioxidant to the RBCs samples in a final concentration 
of 90 µM and the samples were stored at −20 °C. All FAs 
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analyses were performed within a maximum of 4 weeks 
after storage. All study subjects gave informed consent for 
participation in the study.
Methodologies for FAMEs Sample Preparation
Three different lipid extraction–derivatization methods 
were tested in samples of human RBCs, namely a two-
step procedure based on a classic method for lipid extrac-
tion (Folch method), a one-step procedure designated 
as Rapid Method (RM), and a one-step procedure with a 
quick saponification step, designated as Rapid Method with 
Saponification (RMS). Furthermore, for both the proposed 
rapid methods, the optimal transesterification time was 
evaluated. For this purpose, both RM and RMS procedures 
were tested using a transesterification reaction at 90 °C dur-
ing 30 or 60 min. The procedures, totalizing five different 
protocols, were executed as described below.
Lipid Extraction using the Folch Procedure 
with Modifications: Classic Method (CM)
Total lipids were extracted from human RBCs using the 
Folch method [20] with slight modifications. In brief, 150 
µL of RBCs sample was lysed and washed with deionized 
water to obtain cell. Then, 1.5 mL of DCM-methanol solu-
tion (2:1, v/v) containing 25 µg of IS (C19:0 FAME) and 
100 µM of BHT methanolic solution was added to RBCs 
cell. Tubes were capped and vigorously vortexed for 30 s, 
followed by centrifugation for 2 min at 14,000 rpm. The 
lower layer containing the DCM phase was transferred 
to a small glass vial and evaporated under nitrogen gas at 
room temperature. The total lipid components were then 
transmethylated using 2 mL of BF3 methanolic solution at 
90 °C during 30 min. After cooling the samples, NaCl-sat-
urated aqueous solution was added to promote the salting 
out of FAMEs, as well as 1 mL of n-heptane for FAMEs 
extraction. The supernatant containing the FAMEs was 
then transferred to a clean glass vial, evaporated to dryness 
under nitrogen gas and redissolved in 100 µL of n-heptane 
for GC-FID analysis.
Direct Extraction and Transmethylation: Rapid Method 
(RM)
Total RBCs lipids were extracted and FAs were methylated 
using the one-step procedure according to Bicalho and co-
workers [32] with modifications. In brief, in a 7 mL glass 
vial, 2 mL of BF3 methanolic solution was directly added 
to 150 µL of RBCs samples containing 25 µg of IS and 
100 µM of BHT methanolic solution. Vials were capped 
and vigorously vortexed for 30 s, followed by a nitrogen 
flushing to prevent FAMEs degradation. Transmethylation 
was performed at 90 °C and two reaction times were evalu-
ated (30 and 60 min). After cooling the samples, 1 mL of 
n-heptane was added and FAMEs were extracted twice by 
vortex mixing (30 s). Supernatant was then transferred to 
a clean glass vial and evaporated under nitrogen gas. Sam-
ples were resuspended in 100 µL of n-heptane and the GC-
FID analysis was performed.
Direct Extraction and Transmethylation: Rapid Method 
with Saponification (RMS)
To assess the effect of saponification, the above-described 
method was slightly modified and the following protocol 
was used. In a 7 mL glass vial, 150 µL of RBCs sample 
containing 25 µg of IS and 100 µM of BHT methanolic 
solution was added and mixed with 500 µL of methanolic 
KOH solution (0.2 M). Vials were capped and vigorously 
vortexed for 30 s, followed by a nitrogen flushing. Saponi-
fication was performed at 90 °C during 10 min. After cool-
ing the samples, 2 mL of BF3 methanolic solution was 
added and the vials were vortexed for 30 s, followed by 
nitrogen flushing. Transmethylation was performed at 
90 °C and two reaction times were also evaluated (30 and 
60 min). After cooling the samples, 1 mL of n-heptane was 
added and FAMEs were extracted twice by vortex mixing 
(30 s). The supernatant was transferred to a clean glass 
vial and evaporated under nitrogen gas. Finally, samples 
were resuspended in 100 µL of n-heptane and analysed by 
GC-FID.
GC‑FID Analysis
Individual FAMEs were identified using a Bruker® 
SCION 436-GC gas chromatograph equipped with 
a flame ionization detector (GC-FID), a split–split-
less injector and a Bruker CP-8410 autosampler. 
FAMEs were separated using a fused carbon–silica 
column, coated with cyanopropyl phase (CP-Sil 88, 
50 m × 0.25 mm i.d and 0.20 µm film thickness, Agi-
lent J&W). The injector temperature was maintained at 
260 °C, the split ratio was 1:25 and the sample injected 
volume was 1 µL. The carrier gas was helium with a total 
flow rate of 12.4 mL min−1 corresponding to a column 
flow of 1.0 mL min−1. The oven temperature was set 
at 160 °C and held for 3 min, increased at 3 °C min−1 
to 229 °C and maintained for 2 min, giving a total run 
time of 28 min. The FID temperature was set at 270 °C 
with the following gas flow: hydrogen = 35 mL min−1, 
instrument air = 350 mL min−1 and nitrogen make-up 
gas = 30 mL min−1. A sampling frequency of 50 Hz was 
used. Data acquisition and processing were performed 
using the CompassCDS 3.0 (Bruker, Germany) software 
for GC systems.
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Identification and Quantification of FAMES
Sample FAME peaks were identified using the Certified Ref-
erence Material of 37 component FAME mix from Supelco. 
Quantification of individual FA was based on the obtained 
peak area from triplicate sample extractions, each being 
injected three times in the GC-FID. The FAME concentra-
tions (ng µL−1) were calculated using an eight-level calibra-
tion curve individually constructed for each FAME, and nor-
malized based on the peak area of the IS. The first level of 
each FAME was set as the initial concentration of the com-
pound in the Certified Reference Material (37 Component 
FAME Mix, reference CRM-47885) and the following levels 
obtained by serial dilution (Table 2). In addition, some peaks 
that were not present in the Certified Reference Material, 
namely the FAMEs C18:1n7, C18:1n6, C22:4n6, C22:5n6, 
C24:2n6, C22:5n3, were identified based on data from litera-
ture [32] and quantified using the IS (C19:0 FAME) calibra-
tion curve. Finally, the individual amount obtained for each 
FAME was converted to FA concentration using conversion 
factors FAME > FA proposed by Sheppard (1992) [36].
Method Validation
The selected procedure for FA extraction from human 
RBCs and derivatization to FAMEs for GC-FID analysis 
was subjected to validation according to the general guide-
lines for the validation of chromatographic methods [37]. 
With this regard, FID response linearity and the limits of 
detection (LOD) and quantification (LOQ) were calculated, 
as well as the precision (repeatability and intermediate pre-
cision) and recovery of the analytical procedure. The lin-
earity of the FID response was determined from the tripli-
cate analyses of Certified Reference Material containing 37 
component FAME mix and seven serial dilutions prepared 
from the stock solution. Eight-point calibration curves were 
obtained for each FAME by plotting peak area versus con-
centration and linear regressions were calculated. The LOD 
and LOQ were calculated from the standard deviation of 
the blank analysis and the slope of the calibration curves 
of each individual FAME, as described by the International 
Conference on Harmonisation Guideline [38]. Repeatabil-
ity and intermediate precision of the selected method were 
calculated on the basis of the corresponding coefficient of 
variation (CV %). Repeatability (intraday precision) was 
assessed from one sample of RBCs analysed sixfold within 
1 day and the interday precision was determined by analys-
ing the same sample of RBCs in duplicates during 5 days. 
Recovery was assessed by spiking RBCs samples with 
15 and 25 µL of the pure 37 FAMES Certified Reference 
Material, each in duplicate. Recoveries were separately cal-
culated and results presented as the mean value of the spik-
ing assays.
Results and Discussion
Comparison of Sample Preparation Methodologies
As referred, several methodologies previously reported 
for the analysis of FAs in biological matrices are fre-
quently based in two-step protocols. Similar to what 
already has been described for other matrices such as 
plasma [19] and whole blood [32], this work aimed at 
proposing a faster sample preparation methodology 
based on a one-step approach to be used specifically on 
RBCs analysis. For such purpose, different one-step pro-
tocols [designated as rapid methods (RM)] were assayed 
and compared with a classic two-step method (Folch 
method with modifications). For the rapid methods, dif-
ferent parameters were evaluated, namely the methyla-
tion period and the inclusion of saponification reaction. 
Bicalho and co-workers [32] evaluated the derivatization 
yield at several time points (ranging from 5 to 60 min) 
and obtained maximum yields when methylation was 
performed at 90 °C during 30 min. Since a different acid 
catalyst for FAMEs production was used by Bicalho and 
co-workers [32], in this work methylation times of 30 
and 60 min were tested. Additionally, considering that 
the inclusion of saponification reaction is frequently 
mentioned in FA analysis of other matrices, such as 
vegetable oils [39, 40] and meat [41], the inclusion of 
saponification was also assayed, resulting in a total of 
four one-step protocols tested. For all methodologies, 
based on literature data, BHT was used as antioxidant to 
prevent samples FA degradation, C19:0 was used as IS 
and BF3 as a catalyst for FA methylation. BHT, a syn-
thetic antioxidant frequently included in routine analyses 
[33–35], was used since it promotes PUFA stability dur-
ing long-term storage of RBCs (4–17 weeks) at −20 °C 
[42]. C19:0 was selected as IS because this odd-chain FA 
has a microbial origin, therefore inexistent or being pre-
sent only at trace levels in animal tissues [43]. Although 
different odd-chain FAs, namely C13:0 and C15:0 have 
been used in other works, the selected IS has a medium 
size chain, thus being more adequate as it is similar to the 
majority of FAs expected to be found in RBCs. BF3 was 
selected as catalyst for FA methylation due to its avail-
ability as commercial reagent and its generalized use. 
In fact, after the work published by Morrison and Smith 
in 1964 [44] showing that this reagent could be used to 
transesterify most of all lipid classes, BF3 has been inten-
sively applied for the analysis of FA in different matrices 
[5, 13, 17, 22, 25, 27, 32, 34]. Moreover, the use of BF3 
is recommended for FAMEs preparation by the Interna-
tional Union of Pure and Applied Chemistry (IUPAC) 
[45] and the International Association of Official Analyti-
cal Communities (AOAC) [46].
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In this work, FAs were analysed as FAME derivatives 
and the obtained results converted to FA as proposed by 
Sheppard (1982). The results of individual FA (ng µL−1) 
from analysed RBCs using the different evaluated method-
ologies are presented in Table 1. The concentration of total 
saturated (SFA), monounsaturated (MUFA) and polyunsat-
urated (PUFA) FAs is highlighted in Fig. 1. Compared to 
all rapid methods tested, the conventional two-step method 
resulted in a lower number of identified FAMEs (with some 
FAs being detected but below the LOQ) (Table 1) and lower 
yields for most FA groups, with exception for SFA (Fig. 1). 
This is in good agreement with the results reported by 
Böcking et al. [47] and is possibly explained by the clot-
ting of RBCs membrane proteins caused by chloroform, 
which can hamper FA extraction in this particular matrix. 
Furthermore, a lower amount of the IS was recovered using 
this method (data not shown), pointing to an inevitable loss 
of compounds due to sample transfers among vials in the 
separate steps of extraction and methylation. Regarding 
the one-step methods (designated as RM and RMS), the 
four tested protocols led to comparable qualitative FA pat-
terns but different absolute concentrations of individual FA 
and sum of compounds (Table 1). In general, the use of a 
longer methylation period (60 min), either with or without 
Table 1  Comparison of fatty acid (FA) composition (ng µL−1) using different transesterification methods and analysed by GC-FID
The yields of fatty acid are shown as mean (n = 9) ± standard deviation (SD) and coefficient of variation (CV %)
n.q. below LOQ, n.d. below LOD. CM classic method, RM rapid method, RMS rapid method with saponification, SFA saturated fatty acids, 
MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids
Fatty acids CM RM (30 min) RM (60 min) RMS (30 min) RMS (60 min)
Mean ± SD  
(ng µL−1)
CV (%) Mean ± SD  
(ng µL−1)
CV (%) Mean ± SD  
(ng µL−1)
CV (%) Mean ± SD  
(ng µL−1)
CV (%) Mean ± SD  
(ng µL−1)
CV (%)
SFA
 14:0 2.17 ± 0.07 3.3 5.91 ± 0.09 1.5 11.31 ± 0.18 1.6 7.03 ± 0.23 3.3 7.67 ± 0.43 5.6
 15:0 n.q – 0.68 ± 0.01 0.7 1.55 ± 0.05 3.2 1.55 ± 0.08 5.1 1.60 ± 0.01 0.4
 16:0 301.70 ± 18.12 6.0 523.40 ± 0.40 0.1 744.14 ± 28.62 3.8 690.22 ± 17.19 2.5 750.06 ± 6.66 0.9
 17:0 n.q – 2.54 ± 0.08 3.1 6.64 ± 0.29 4.4 4.10 ± 0.77 1.7 6.20 ± 0.19 3.0
 18:0 260.07 ± 7.26 2.8 394.21 ± 8.61 2.2 515.78 ± 14.52 2.8 543.16 ± 30.26 5.6 553.71 ± 2.17 0.4
 20:0 9.18 ± 0.04 0.4 6.46 ± 0.16 2.4 11.12 ± 0.54 4.9 7.03 ± 0.58 8.3 11.04 ± 0.04 0.4
 22:0 4.29 ± 1.03 23.9 42.74 ± 1.53 3.6 77.57 ± 4.38 5.6 53.96 ± 0.46 0.8 76.17 ± 1.29 1.7
 23:0 n.d. – n.d. – 2.61 ± 0.16 6.3 n.d. – 1.72 ± 0.01 0.6
 24:0 2.23 ± 0.00 0.2 18.08 ± 0.21 1.1 93.28 ± 4.55 4.6 17.30 ± 0.55 3.0 87.83 ± 1.75 1.9
MUFA
 16:1 n.d. – 7.43 ± 0.24 3.2 11.02 ± 0.35 3.2 10.41 ± 0.23 1.7 10.42 ± 0.08 0.8
 18:1n9t n.d. – n.d. – n.d. – 13.35 ± 0.71 5.3 9.08 ± 0.08 0.9
 18:1n9c 66.77 ± 19.69 29.5 242.88 ± 5.30 2.2 316.40 ± 1.53 0.5 317.07 ± 0.32 0.1 316.28 ± 3.59 1.1
 18:1n7 n.q – 15.66 ± 0.31 2.0 21.54 ± 0.02 0.1 21.79 ± 0.42 1.9 20.87 ± 0.46 2.2
 18:1n6 n.d. – 3.51 ± 0.13 3.6 9.49 ± 0.51 5.4 7.35 ± 0.48 6.5 5.42 ± 0.59 10.9
 20:1 n.q – 0.79 ± 0.04 5.2 1.08 ± 0.02 2.1 1.27 ± 0.05 4.3 1.35 ± 0.02 1.4
 22:1n9 n.d. – n.d. – n.d. – 4.35 ± 0.18 4.2 2.72 ± 0.06 2.3
 24:1 n.q – 16.17 ± 0.48 3.0 102.41 ± 3.50 3.4 14.64 ± 0.58 4.0 86.82 ± 1.84 2.1
n-6 PUFA
 18:2n6c 37.18 ± 15.70 42.2 186.11 ± 6.83 3.7 243.24 ± 1.94 0.8 225.30 ± 3.76 1.7 227.7 5 ± 3.82 1.7
 20:2 n.d. – 4.77 ± 0.04 0.9 6.95 ± 0.15 2.1 6.82 ± 0.06 0.8 6.92 ± 0.06 0.8
 20:4n6 42.60 ± 15.01 35.2 316.18 ± 11.27 3.6 427.60 ± 0.28 0.1 382.96 ± 4.11 1.0 386.46 ± 6.09 1.6
 22:4n6 7.55 ± 2.93 38.8 76.35 ± 2.83 3.7 89.49 ± 0.13 0.1 93.95 ± 0.80 0.8 85.93 ± 1.11 1.3
 22:5n6 n.d. – 13.23 ± 0.68 5.1 21.22 ± 0.05 0.3 18.07 ± 0.09 0.5 19.36 ± 0.19 1.0
 24:2n6 n.d. – n.q – 10.27 ± 0.30 3.0 n.q – 9.24 ± 0.15 1.6
n-3 PUFA
 18:3n3 n.q – 3.03 ± 0.07 2.2 3.78 ± 0.07 1.8 4.25 ± 0 26 6.0 4.22 ± 0.11 2.6
 20:5n3 n.d. – 2.98 ± 0.08 2.4 6.17 ± 0.03 0.5 4.69 ± 0.20 4.1 4.64 ± 0.23 4.7
 22:5n3 n.d. – 23.75 ± 1.03 4.3 29.51 ± 0.05 0.2 29.99 ± 0.06 0.2 29.15 ± 0.42 1.4
 22:6n3 23.02 ± 7.92 34.4 125.47 ± 6.81 5.4 166.70 ± 1.24 0.7 151.08 ± 3.01 2.0 152.85 ± 1.59 1.0
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KOH saponification, allowed obtaining higher amounts (ng 
µL−1) for most FAMEs (Fig. 1), with particular emphasis 
for lignoceric acid (C24:0) and very long-chain FAs doc-
osanoic (C22:0), tricosanoic acid (23:0) and nervonic acid 
(C24:1) (Table 1). On the other hand, the use of saponi-
fication allowed the detection of some important trans 
and cis FAs that were not detected with other methods 
(Table 1), namely the trans isomer of oleic acid, elaidic acid 
(C18:1n9t), which is the major trans FA frequently associ-
ated with increased risk of cardiovascular diseases [1, 48], 
and the cis erucic acid (C22:1n9), which has been related 
with myocardial lesions [49]. Considering that the one-step 
Fig. 1  Comparison of FA 
groups (ng µL−1) obtained 
from RBCs using different 
transesterification methods (CM 
conventional two-step method, 
RM rapid method, RMS rapid 
method with saponification). 
SFA saturated fatty acids, MUFA 
monounsaturated fatty acids, 
PUFA polyunsaturated fatty 
acids; error bars the standard 
deviation, all results are shown 
as mean ± SD (n = 9)
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Fig. 2  GC-FID chromatogram obtained from the analysis of an RBC sample with the selected method (RMS-60 min) evidencing the separation 
profile of the identified unsaturated C18 isomers and the internal standard (C19:0)
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RMS method with a longer methylation period (60 min) 
allowed to simultaneously achieve a high extraction yield 
for most compounds, as well as to identify a higher number 
of FAs, with particular emphasis for the detection of trans 
FAs, it was selected as being the most suitable methodology 
for the intended purposes (being used in future biomedical/
epidemiological studies). Therefore, it was further submit-
ted to in-house validation, where the most common valida-
tion parameters were evaluated. A typical chromatogram 
obtained for a RBC sample analysed using the selected 
method (rapid method with saponification and 60 min meth-
ylation period, RMS-60 min) is shown in Fig. 2.
Linearity and Sensitivity of the GC‑FID Analysis
Table 2 presents the results obtained for the linearity, LOD 
and LOQ. As referred, for each compound an eight-level 
calibration curve was constructed using the peak area ver-
sus concentration of the standard (µg µL−1). An adequate 
linearity over the concentration range studied was obtained 
for all investigated FAMEs, with correlation coefficient 
values (r2) higher than 0.999, except for C20:0 with an 
r2 value of 0.998 (Table 2). To calculate the linear FID 
response for each FAME, slope and intercept of the individ-
ual FA were used. The slopes values for the majority of the 
FAMEs were similar, nevertheless there were some excep-
tions demonstrating the importance of quantifying each 
compound using appropriate calibration curves obtained 
with the corresponding standard. To determine the sensitiv-
ity of the FAMEs analysis, LOD and LOQ were calculated 
as three times and ten times standard deviation of signal-
to-noise (S/N) ratio. As can be observed in Table 2, LOD 
ranged between 0.073 and 0.205 ng µL−1 and LOQ ranged 
between 0.242 and 0.631 ng µL−1.
Table 2  Linearity and 
sensitivity of the fatty acids 
methyl esters (FAME) detection 
by GC-FID analysis
Rt retention time, r2 coefficient of correlation, LOD limit of detection, LOQ limit of quantification
a Based on eight-point calibration curve for each individual FA
b FAs identified by comparison with published data [32] and quantified using the C19:0 FAME calibration 
curve
Fatty acids Rt (min) Range (ng µl−1) Slopea Intercepta r2 LOD (ng µl−1) LOQ (ng µl−1)
14:0 6.37 400.0–0.82 7656.9 6.9509 0.9995 0.199 0.588
15:0 7.21 200.0–0.41 7627.2 5.1976 0.9997 0.200 0.590
16:0 8.24 602.0–1.24 7894.3 9.2202 0.9995 0.193 0.570
16:1 9.00 199.0–0.41 7781.5 4.3558 0.9995 0.196 0.578
17:0 9.42 200.0–0.41 7806.3 4.6604 0.9995 0.195 0.577
18:0 10.78 399.0–0.82 7984.7 8.8242 0.9996 0.191 0.564
18:1n9t 11.32 200.0–0.41 7597.8 5.0329 0.9996 0.200 0.592
18:1n9c 11.57 399.0–0.82 8053.0 7.5348 0.9995 0.189 0.559
18:1n7b 11.67 600.0–2.34 8440.7 17.552 0.9999 0.073 0.242
18:1n6b 11.79 600.0–2.34 8440.7 17.552 0.9999 0.073 0.242
18:2n6c 12.87 200.0–0.41 7851.2 5.0025 0.9995 0.194 0.573
20:0 13.82 402.0–0.83 8632.8 15.848 0.9988 0.176 0.521
20:1 14.48 199.0–0.41 7825.9 4.2181 0.9996 0.195 0.575
18:3n3 14.61 200.0–0.41 8068.9 5.7257 0.9997 0.189 0.558
20:2 16.01 200.0–0.41 7906.8 4.704 0.9997 0.193 0.569
22:0 17.02 601.0–1.24 7682.7 15.337 0.9997 0.198 0.586
22:1n9 17.67 201.0–0.41 7438.7 5.0574 0.9997 0.205 0.605
20:4n6 17.81 403.0–0.83 7680.9 7.601 0.9997 0.198 0.586
23:0 18.75 200.0–0.41 7994.7 8.2742 0.9997 0.190 0.563
20:5n3 19.57 399.0–0.76 8131.5 11.725 0.9998 0.187 0.554
24:0 20.43 199.0–0.43 7138.5 5.4313 0.9997 0.213 0.631
24:1 21.17 200.0–0.41 8021.6 7.7355 0.9997 0.190 0.561
22:4n6b 21.20 600.0–2.34 8440.7 17.552 0.9999 0.073 0.242
22:5n6b 21.89 600.0–2.34 8440.7 17.552 0.9999 0.073 0.242
24:2n6b 22.46 600.0–2.34 8440.7 17.552 0.9999 0.073 0.242
22:5n3b 22.93 600.0–2.34 8440.7 17.552 0.9999 0.073 0.242
22:6n3 23.66 201.0–0.41 7651.3 6.6866 0.9996 0.199 0.588
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Precision and Recovery
An important aspect when implementing a new meth-
odology in clinical studies is that it should be thoroughly 
evaluated before being used. Nevertheless, several clinical 
and nutritional studies reported so far do not give any infor-
mation regarding the use of methodologies validated for the 
specific analysis of RBCs, which is a matrix very different 
from tissues, plasma and whole blood.
To assess the precision of the selected method (RMS), 
repeatability and intermediate precision were determined 
as the coefficient of variation (CV %) obtained for intraday 
and interday precision, respectively. The obtained experi-
mental CV % was in the range of 1.0–4.9 % for repeatabil-
ity and 2.2–6.5 % for intermediate precision (Table 3). The 
comparison of these values with the theoretical repeatabil-
ity and intermediate precision CV % (obtained from the 
Horwitz equation and the Horrat value for an analyte ratio 
of 10−6 (ng µL−1) as reported in the guidelines for vali-
dation of chromatographic methods [37]) showed a high 
precision of the method, as the experimental values were 
always lower than the theoretical coefficient of variation 
recommended for this order of analyte level. However, it 
should be referred that, in general, there was an increase 
in the coefficient of variation calculated for interday preci-
sion when compared to intraday precision values obtained 
for the same compounds. This was particularly noticed for 
the unsaturated acids, possibly because they are more sus-
ceptible to oxidation. Therefore, besides adding an anti-
oxidant, the samples should be handled under an atmos-
phere of inert gas and stored at −20 °C whenever needed. 
Finally, the accuracy of the selected method was assessed 
by calculating the mean recovery of the individual FAMEs 
(Table 3) from samples of RBCs spiked with 15 and 25 
µL of the stock solution of 37 FAMEs Certified Reference 
Material (10 mg mL−1), and subjected to FAMEs extrac-
tion with the selected method (RMS with 60 min meth-
ylation). In general, recoveries of each FAME exceeded 
80 %, which is in good agreement with the recommended 
theoretical recovery values (80–110 %) [37]. Although not 
considered due to their absence in the analysis of RBCs, 
it can be referred that lower recovery values (ranging 
from 23.7 to 77.4 %) were obtained for short chain FAs, 
namely C10:0, C11:0, C12:0 and C13:0 possibly due to 
incomplete extraction of the compounds to n-heptane. Low 
recoveries for short chain FAs were already reported by 
Firl et al. [19] when developing and validating a method-
ology for FA analysis in human plasma. However, higher 
recovery was attained in the present work for myristic 
acid (C14:0) compared to the values achieved for plasma 
reported by Firl et al. [19].
Application of the Method
As an application example, the proposed validated method 
was applied for the analysis of a RBC sample obtained 
from a patient with type 2 Diabetes mellitus (T2DM) and 
Table 3  Validation parameters for the selected methodology (RMS-
60 min) to analyse fatty acids in human RBCs
Bold highlights the mean CV (%) of the total SFA, MUFA, n-3 PUFA 
and n-6 PUFA
SFA saturated fatty acids, MUFA monounsaturated fatty acids, PUFA 
polyunsaturated fatty acids, CV (%) coefficient of variation, n.a. not 
applicable (without recovery data as they are not present in standard 
mix)
a sixfold determination of the sample at 1 day (n = 12)
b determination of the sample in duplicates during 5 days in a week 
(n = 10)
c Identified FAs by comparison with published data [32]
Fatty acids Repeatability Intermediate 
precision
Accuracy
CV (%)a CV (%)b Recovery (%) CV (%)
14:0 2.2 4.5 86.1 ± 9.2 10.7
15:0 3.0 5.3 90.8 ± 9.4 10.3
16:0 2.1 3.1 96.6 ± 7.8 8.2
17:0 1.6 2.6 99.3 ± 10.9 11.0
18:0 2.2 3.8 98.1 ± 7.3 7.5
20:0 2.2 3.9 90.2 ± 8.1 9.0
22:0 1.9 3.5 72.4 ± 10.6 14.6
23:0 3.4 4.6 102.4 ± 11.0 10.8
24:0 2.2 3.5 97.2 ± 9.6 9.9
SFA 2.3 3.9 – –
16:1 2.6 2.3 91.2 ± 9.7 10.7
18:1n9t 2.3 2.2 95.9 ± 8.1 8.4
18:1n9c 2.0 3.1 101.5 ± 10.6 10.5
18:1n7c 2.1 2.6 n.a. n.a.
18:1n6c 1.0 3.2 n.a. n.a.
20:1 2.6 5.3 87.8 ± 9.5 10.8
22:1n9 1.4 4.6 87.6 ± 7.2 8.2
24:1 2.9 5.7 106.5 ± 21.3 20.0
MUFA 2.1 3.6 – –
18:2n6c 2.1 3.2 122.8 ± 6.0 4.9
20:2 2.4 3.5 97.9 ± 12.4 12.6
20:4n6 2.3 3.4 101.1 ± 25.8 25.6
22:4n6c 2.5 5.7 n.a. n.a.
22:5n6c 4.6 6.5 n.a. n.a.
24:2n6c 1.8 4.5 n.a. n.a.
n‑6 PUFA 2.6 4.5 – –
18:3n3 4.9 5.8 97.4 ± 10.2 10.5
20:5n3 2.5 3.3 93.6 ± 14.2 15.2
22:5n3c 1.7 3.0 n.a. n.a.
22:6n3 1.6 2.8 128.4 ± 3.7 2.9
n‑3 PUFA 2.7 3.7 – –
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results compared with the values obtained for a healthy vol-
unteer (without T2DM) (Fig. 3). The graphic presented in 
Fig. 3 shows a higher MUFA content in the T2DM RBC 
sample which has already been described in this type of 
patients being attributed to a stimulation of Δ9 desatu-
rase enzymes, which converts SFA in MUFA, caused by 
increased glucose uptake in patients with T2DM [6]. Also, 
in good agreement with the literature [6] results showed 
that the patient with T2DM presented higher levels of some 
long-chain SFA such as arachidic acid (C20:0) and lower 
levels of PUFA, in particular of the omega-3 docosahexae-
noic acid (DHA, C22:6n3), although showing higher con-
tents of the omega-6 arachidonic acid (AA, C20:4n6).
Conclusions
In this work, an optimized one-step sample preparation 
methodology for FA analysis in human RBCs samples is 
proposed. Based on the presented results, the validated 
methodology for the quantification of FAs in human RBCs 
showed to be fast, sensitive, precise and accurate, thus 
demonstrating its suitability as a useful tool that can be 
used in clinical and epidemiological surveys including a 
high number of samples.
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